Prediction of 5 Year Severe Exacerbation and Mortality Risk by Baseline Exacerbation Status in the US- Application of the ETHOS Trial to a Real-World Analysis of COPD Patients | Zendy

AI Assistant Blog Pricing

Prediction of 5 Year Severe Exacerbation and Mortality Risk by Baseline Exacerbation Status in the US- Application of the ETHOS Trial to a Real-World Analysis of COPD Patients

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.